Literature DB >> 19378444

Process and predictors of drug treatment referral and referral uptake at the Sydney Medically Supervised Injecting Centre.

Jo Kimber1, Richard P Mattick, John Kaldor, Ingrid van Beek, Stuart Gilmour, Jake A Rance.   

Abstract

INTRODUCTION AND AIMS: Low-threshold drug services such as drug consumption rooms (DCRs) have been posited as referral gateways to drug treatment for injecting drug users (IDUs). We examined the process and predictors of drug treatment referral and referral uptake at an Australian DCR. DESIGN AND METHODS: We undertook behavioural surveillance of the Sydney Medically Supervised Injecting Centre (MSIC) client cohort between May 2001 and October 2002. Data were collected for 3715 IDUs on demographics, injecting and drug use behaviours at registration and all subsequent MSIC service utilisation, including referrals. Referral uptake (defined as presentation for assessment at the relevant agency) was traced via reply-paid postcards included with written referrals.
RESULTS: Sixteen per cent of clients who received written referrals to drug treatment had confirmed drug treatment referral uptake. Factors associated with drug treatment referral were frequent MSIC attendance [adjusted odds ratios (AOR = 9.4], receipt of written health (AOR = 4.8) or psychosocial (AOR = 4.3) referrals, heroin as main drug injected (AOR = 1.9) and completion of high school education (AOR = 1.6). Factors associated positively with drug treatment referral uptake were recent sex work (AOR = 2.6) and at least daily injection (AOR = 2.3). Previous psychiatric illness or self-harm was associated negatively with drug treatment referral uptake (AOR = 0.2). DISCUSSION AND
CONCLUSIONS: MSIC engaged IDUs successfully in drug treatment referral and this was associated with presentation for drug treatment assessment and other health and psychosocial services. To improve rates of drug treatment referral and uptake, those with a history of mental health issues may require more intensive referral and case management.

Entities:  

Mesh:

Year:  2008        PMID: 19378444     DOI: 10.1080/09595230801995668

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  19 in total

1.  Impact of in-patient research participation on subsequent heroin use patterns: implications for ethics and public health.

Authors:  Perrine Roux; Claudia Tindall; Lionel Fugon; Janet Murray; Suzanne K Vosburg; Phillip Saccone; Maria A Sullivan; Jeanne M Manubay; Ziva D Cooper; Jermaine D Jones; Richard W Foltin; Sandra D Comer
Journal:  Addiction       Date:  2012-03       Impact factor: 6.526

2.  Analyzing components of Community Reinforcement and Family Training (CRAFT): Is treatment entry training sufficient?

Authors:  Kimberly C Kirby; Lois A Benishek; MaryLouise E Kerwin; Karen L Dugosh; Carolyn M Carpenedo; Elena Bresani; James A Haugh; Yukiko Washio; Robert J Meyers
Journal:  Psychol Addict Behav       Date:  2017-08-24

Review 3.  Public Health and Public Order Outcomes Associated with Supervised Drug Consumption Facilities: a Systematic Review.

Authors:  Mary Clare Kennedy; Mohammad Karamouzian; Thomas Kerr
Journal:  Curr HIV/AIDS Rep       Date:  2017-10       Impact factor: 5.071

4.  Effectiveness of intervention on improvement of drug use among methadone maintained adults.

Authors:  Adeline M Nyamathi; Karabi Nandy; Barbara Greengold; Mary Marfisee; Farinaz Khalilifard; Allan Cohen; Barbara Leake
Journal:  J Addict Dis       Date:  2011-01

5.  Injection drug use cessation and use of North America's first medically supervised safer injecting facility.

Authors:  Kora DeBeck; Thomas Kerr; Lorna Bird; Ruth Zhang; David Marsh; Mark Tyndall; Julio Montaner; Evan Wood
Journal:  Drug Alcohol Depend       Date:  2010-08-30       Impact factor: 4.492

6.  Health impacts of a scale-up of supervised injection services in a Canadian setting: an interrupted time series analysis.

Authors:  Mary Clare Kennedy; Kanna Hayashi; M-J Milloy; Miranda Compton; Thomas Kerr
Journal:  Addiction       Date:  2021-12-02       Impact factor: 6.526

7.  Supervised Injection Facility Utilization Patterns: A Prospective Cohort Study in Vancouver, Canada.

Authors:  Mary Clare Kennedy; David C Klassen; Huiru Dong; M-J S Milloy; Kanna Hayashi; Thomas H Kerr
Journal:  Am J Prev Med       Date:  2019-08-01       Impact factor: 5.043

Review 8.  HIV among injecting drug users: current epidemiology, biologic markers, respondent-driven sampling, and supervised-injection facilities.

Authors:  Don C Des Jarlais; Kamyar Arasteh; Salaam Semaan; Evan Wood
Journal:  Curr Opin HIV AIDS       Date:  2009-07       Impact factor: 4.283

9.  Use of on-site detoxification services co-located with a supervised injection facility.

Authors:  Andrew Gaddis; Mary Clare Kennedy; Ekaterina Nosova; M-J Milloy; Kanna Hayashi; Evan Wood; Thomas Kerr
Journal:  J Subst Abuse Treat       Date:  2017-08-08

10.  Assisted injection within supervised injection services: Uptake and client characteristics among people who require help injecting in a Canadian setting.

Authors:  Mary Clare Kennedy; M-J Milloy; Kanna Hayashi; Elizabeth Holliday; Evan Wood; Thomas Kerr
Journal:  Int J Drug Policy       Date:  2020-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.